Alexandra Martínez-Roca/X
Jun 17, 2025, 06:23
Alexandra Martínez-Roca: Privileged to Share the Stage With Leading Voices In Hematology at EHA 2025
Alexandra Martínez-Roca, Hematologist at the Hematology Department at the Hospital Clínic Barcelona, shared a post on X by Nico Gagelmann, Chair of CAR-T for the plasma cell disorder committee at the EBMT, adding:
“Felt privileged to share the stage with leading voices in hematology at EHA 2025.
Thanks Nico for the support and waking up early on a Sunday morning.”
Quoting Nico Gagelmann‘s post:
“Fascinating at the European Hematology Association and The EBMT session at EHA 2025 chaired by Anna Sureda and Konstanze Döhner covering New strategies for mismatched SCT (advances in donor selection and immunosuppression) by F Ciceri.
The role of CAR-T as bridging to SCT (CAR-T vs SCT, or CAR-T and SCT?) by Mari Subklewe.
Outpatient CAR-T by Alexandra Martínez-Roca.”
Read Also 25 Posts Not to Miss from EHA 2025
-
Sep 9, 2026, 15:10Pablo Corral: Is the Lp(a) Hypothesis Wrong?
-
Sep 9, 2026, 14:54Agnes Kisakye: Expanding Point-of-Care Ultrasound and Surgical Interventions for Hemophilia in Uganda
-
Sep 9, 2026, 14:52Jan Sloves: Addressing Diagnostic and Treatment Variability in Pelvic-Origin Varicose Veins
-
Sep 9, 2026, 14:48The French Care Pathway for Gene Therapy in Haemophilia B – CRH French Reference Center for Hemophilia Lyon
-
Sep 9, 2026, 14:43David McIntosh: The Ethics of Plasma Donation
-
Sep 9, 2026, 14:42Thirunavukkarasu Angappan: Factor VIII and IX Didn’t Get Viral-Safety Rules Until the 1980s
-
Sep 9, 2026, 14:30Alejandro González Veliz: 2026 ESC Guidelines Expand Cardiac Rehabilitation Beyond Post-Event Recovery
-
Sep 9, 2026, 13:59Natalie Arnold: Biomarkers and the Hidden Burden of CHD
-
Sep 9, 2026, 13:11Ron DePinho: A Negative Trial Does Not Repudiate Inflammation as a Cardiovascular Target